These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31477715)

  • 1. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
    Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D
    Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.
    Andreiuolo F; Varlet P; Tauziède-Espariat A; Jünger ST; Dörner E; Dreschmann V; Kuchelmeister K; Waha A; Haberler C; Slavc I; Corbacioglu S; Riemenschneider MJ; Leipold A; Rüdiger T; Körholz D; Acker T; Russo A; Faber J; Sommer C; Armbrust S; Rose M; Erdlenbruch B; Hans VH; Bernbeck B; Schneider D; Lorenzen J; Ebinger M; Handgretinger R; Neumann M; van Buiren M; Prinz M; Roganovic J; Jakovcevic A; Park SH; Grill J; Puget S; Messing-Jünger M; Reinhard H; Bergmann M; Hattingen E; Pietsch T
    Brain Pathol; 2019 Mar; 29(2):205-216. PubMed ID: 30246434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes.
    Takadera M; Satomi K; Szulzewsky F; Cimino PJ; Holland EC; Yamamoto T; Ichimura K; Ozawa T
    Acta Neuropathol Commun; 2020 Nov; 8(1):203. PubMed ID: 33228790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis.
    Szulzewsky F; Arora S; Hoellerbauer P; King C; Nathan E; Chan M; Cimino PJ; Ozawa T; Kawauchi D; Pajtler KW; Gilbertson RJ; Paddison PJ; Vasioukhin V; Gujral TS; Holland EC
    Genes Dev; 2020 Aug; 34(15-16):1051-1064. PubMed ID: 32675324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis.
    Hu X; Wu X; Berry K; Zhao C; Xin D; Ogurek S; Liu X; Zhang L; Luo Z; Sakabe M; Trubicka J; Łastowska M; Szulzewsky F; Holland EC; Lee L; Hu M; Xin M; Lu QR
    Nat Cell Biol; 2023 Feb; 25(2):323-336. PubMed ID: 36732631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
    Parker M; Mohankumar KM; Punchihewa C; Weinlich R; Dalton JD; Li Y; Lee R; Tatevossian RG; Phoenix TN; Thiruvenkatam R; White E; Tang B; Orisme W; Gupta K; Rusch M; Chen X; Li Y; Nagahawhatte P; Hedlund E; Finkelstein D; Wu G; Shurtleff S; Easton J; Boggs K; Yergeau D; Vadodaria B; Mulder HL; Becksfort J; Gupta P; Huether R; Ma J; Song G; Gajjar A; Merchant T; Boop F; Smith AA; Ding L; Lu C; Ochoa K; Zhao D; Fulton RS; Fulton LL; Mardis ER; Wilson RK; Downing JR; Green DR; Zhang J; Ellison DW; Gilbertson RJ
    Nature; 2014 Feb; 506(7489):451-5. PubMed ID: 24553141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP1/TAZ drives ependymoma-like tumour formation in mice.
    Eder N; Roncaroli F; Domart MC; Horswell S; Andreiuolo F; Flynn HR; Lopes AT; Claxton S; Kilday JP; Collinson L; Mao JH; Pietsch T; Thompson B; Snijders AP; Ultanir SK
    Nat Commun; 2020 May; 11(1):2380. PubMed ID: 32404936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
    Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
    J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
    Ota M; Sasaki H
    Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation.
    Jha S; Mulgulwar PB; Sharma MC; Purkait S; Pattnaik A; Sable MN
    Neurol India; 2023; 71(5):1011-1014. PubMed ID: 37929446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin.
    Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC
    J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis.
    Zhou Y; Huang T; Cheng AS; Yu J; Kang W; To KF
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB.
    Ozawa T; Arora S; Szulzewsky F; Juric-Sekhar G; Miyajima Y; Bolouri H; Yasui Y; Barber J; Kupp R; Dalton J; Jones TS; Nakada M; Kumabe T; Ellison DW; Gilbertson RJ; Holland EC
    Cell Rep; 2018 Jun; 23(13):3787-3797. PubMed ID: 29949764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
    Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.
    Simile MM; Latte G; Demartis MI; Brozzetti S; Calvisi DF; Porcu A; Feo CF; Seddaiu MA; Daino L; Berasain C; Tomasi ML; Avila MA; Feo F; Pascale RM
    Oncotarget; 2016 Aug; 7(31):49194-49216. PubMed ID: 27359056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid shear stress activates YAP1 to promote cancer cell motility.
    Lee HJ; Diaz MF; Price KM; Ozuna JA; Zhang S; Sevick-Muraca EM; Hagan JP; Wenzel PL
    Nat Commun; 2017 Jan; 8():14122. PubMed ID: 28098159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEAD mediates YAP-dependent gene induction and growth control.
    Zhao B; Ye X; Yu J; Li L; Li W; Li S; Yu J; Lin JD; Wang CY; Chinnaiyan AM; Lai ZC; Guan KL
    Genes Dev; 2008 Jul; 22(14):1962-71. PubMed ID: 18579750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.
    Arabzade A; Zhao Y; Varadharajan S; Chen HC; Jessa S; Rivas B; Stuckert AJ; Solis M; Kardian A; Tlais D; Golbourn BJ; Stanton AJ; Chan YS; Olson C; Karlin KL; Kong K; Kupp R; Hu B; Injac SG; Ngo M; Wang PR; De León LA; Sahm F; Kawauchi D; Pfister SM; Lin CY; Hodges HC; Singh I; Westbrook TF; Chintagumpala MM; Blaney SM; Parsons DW; Pajtler KW; Agnihotri S; Gilbertson RJ; Yi J; Jabado N; Kleinman CL; Bertrand KC; Deneen B; Mack SC
    Cancer Discov; 2021 Sep; 11(9):2200-2215. PubMed ID: 33741710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers.
    Stein C; Bardet AF; Roma G; Bergling S; Clay I; Ruchti A; Agarinis C; Schmelzle T; Bouwmeester T; Schübeler D; Bauer A
    PLoS Genet; 2015 Aug; 11(8):e1005465. PubMed ID: 26295846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.